<DOC>
	<DOC>NCT01192568</DOC>
	<brief_summary>This study will evaluate the safety and efficacy of Oxybutynin Chloride 10% Topical Gel in children 3 to less than 17 years old, who have overactive bladder due to a neurogenic condition. Children will be treated with 0.75 g of gel/day for two weeks. Patients will then return to the clinic for a potential dose titration. At this time their dose may be adjusted up to 1g/day, down to 0.5g/day, or remain the same at 0.75g of gel/day depending on the individual response and tolerability. The total treatment time is 14 weeks and total time on the study is 16 weeks.</brief_summary>
	<brief_title>Safety and Efficacy Evaluation of Oxybutynin Topical Gel In Children With Neurogenic Bladder</brief_title>
	<detailed_description>This study will use a two-part, multicenter, dose-titration study in pediatric patients with a detrusor overactivity associated with a neurological condition</detailed_description>
	<mesh_term>Urinary Bladder, Neurogenic</mesh_term>
	<mesh_term>Urinary Bladder, Overactive</mesh_term>
	<mesh_term>Oxybutynin</mesh_term>
	<mesh_term>Mandelic Acids</mesh_term>
	<criteria>3 years to &lt; 17 years Neurogenic bladder Neurological condition CIC Have anatomical bladder abnormalities Sensitivity to anticholinergics Bladder augmentation</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>